GLP-1 receptor agonists and obstructive lung disease: Beyond metabolic control to respiratory outcomes
{{output}}
Chronic obstructive pulmonary disease (COPD) and asthma are increasingly recognized as systemic conditions shaped by metabolic comorbidities, particularly obesity and type 2 diabetes mellitus (T2DM). Beyond traditional airway-directed therapies, increasing att... ...
